CEVA Animal Health has added to its joint care range with the launch of Meloxidyl Injection to help control post-operative pain in cats and dogs and alleviate musculoskeletal pain in dogs.
CEVA says Meloxidyl Injection is bioequivalent to the leading meloxicam injection and dogs can be given Meloxidyl oral suspension 24 hours after Meloxidyl Injection has been administered.
Meloxidyl Injection is available in 10ml bottles containing 5mg/ml of meloxicam.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Fifty young people from low and middle income backgrounds will have the opportunity to learn what it takes to become a vet and prepare to apply to a veterinary school, at a summer school run by the Sutton Trust and the Royal Veterinary College.
The RVC joins nine other UK universities in providing 1900 summer school places this year, helped by a three-year grant of £750,000 to the summer school programme from Barclays.
Each year, around 1,500 applicants apply for 664 places at the seven veterinary schools in the UK.
The 50 successful applicants to the RVC summer school this year will enter a week-long residential course with all expenses covered. The academic programme will focus on Bioveterinary Sciences, Veterinary Medicine and Veterinary Nursing taught by full-time academic staff. It will include practical dissections, clinical skills, farm-based sessions and laboratory periods. The participants will also be given sessions on the application process and interviews.
Sir Peter Lampl, chairman of the Sutton Trust and of the Education Endowment Foundation, said: "I'm delighted that the Royal Veterinary College has joined the Sutton Trust UK summer school programme. Veterinary courses are highly competitive, but it is vital that young people from low and middle income backgrounds have a fair chance to access them.
"Veterinary life is an attractive career choice for many bright young people, not just for the interest and variety of the work but also for the earning opportunities. The 50 students who enrol at the Royal Veterinary College this year will be given the best opportunity to prepare for university courses through our highly successful summer school model." Professor Stuart Reid, Principal at the Royal Veterinary College, said: "For many years the Royal Veterinary College has been focused on widening access to veterinary education to the most able students regardless of their background. The Sutton Trust has a long and successful tradition of supporting under-privileged students into higher education and we are proud to be working with the Trust's summer school programme.
"We hope that the summer school will demonstrate the broad range of exciting opportunities available to students with an interest in veterinary science and encourage more students from non-traditional backgrounds to consider a veterinary career."
Young people interested in applying to Sutton Trust summer schools can find more information at http://www.suttontrust.com/students/uk-summer-schools/
Eli Lilly and Company, which owns Elanco Animal Health, has announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in cash.
Lilly says that on completion of the deal, Elanco will be the second-largest animal health company in terms of global revenue. It will also solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.
As part of the agreement, Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees.
The transaction is expected to be completed by the end of the first quarter of 2015, subject to clearance under the U.S. Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.
John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer said: "Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses.
"Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth. Global trends suggest continued sustained demand for animal health products in the years ahead. Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs."
The Kennel Club has announced that crossbreed dogs are to have their own event at Crufts for the first time next year.
For the first time in its twelve year history, the grand final of Scruffts, the crossbreed dog competition run by the Kennel Club, will culminate at Crufts at the NEC in Birmingham. The winners of the four Scruffts categories - Child's Best Friend, Golden Oldie, Prettiest Crossbreed Bitch and Most Handsome Crossbreed Dog - will battle it out for the ultimate title of Scruffts Family Crossbreed of the Year.
Scruffts, sponsored by James Wellbeloved, has held heats across the UK over the course of the year and the winners of each category in every heat have been invited to Discover Dogs in London to compete in the class finals on Saturday 10th November. Winners of the four classes at Discover Dogs will now go on to Crufts 2013, where they will compete for the overall Scruffts title.
Caroline Kisko, Secretary of the Kennel Club, said: "Scruffts is a fantastic competition and we're very much looking forward to seeing the four class winners come to Crufts for the final next year. We have had some fantastic Scruffts champions in the past and I am sure we can expect to see a really special dog take the title once again."
There is still time to qualify for the Scruffts class finals, with heats taking place at CSJ Canine Max 2012 in Cirencester Park on Saturday 13th October and the East of England Autumn Show in Peterborough on Sunday 14th October.
Bayer Animal Health, manufacturer of Advocate, is launching an advertising campaign to support its 'Be Lungworm Aware' initiative, which aims to educate pet owners on the spread of Angiostrongylus vasorum and encourage them to seek advice from their local veterinary practice.
The campaign will see a new TV 'public information' style advertisement targeting dog owners. It will air on 20 national TV channels during April including ITV1, 2 and 3, Sky 1, 2 and 3, More 4 and Film4, with air time dedicated to GMTV and daytime ITV.
The TV advertising campaign will focus on the parasite's intermediate hosts - slugs and snails - and the ease in which dogs can become infected with the parasite by picking up something as simple as a toy with a slug attached to it.
Print advertisements will also be running in national newspapers and women's consumer magazines with a focus on publications read by pet owners.
Marketing support material is available for veterinary practices wishing to participate in the 'Be Lungworm Aware' initiative. For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.
The Pet Doctors Group has announced that it will continue its New Graduate Programme for Autumn 2010, an initiative which the company says has proved successful since its launch in 2008. The aim of the scheme is to appoint new graduates to work in a selected number of its practices, spread across the South East of England.
Brodie Collins, Area Manager at Pet Doctors, will be meeting final year students at the Bristol University School of Veterinary Science, the Royal Veterinary College in London and the University of Cambridge Veterinary School during February and March 2010 to promote the scheme and explain the firm's approach to supporting graduates during their critical first year in practice. Successful applicants will be shortlisted by August 2010 with appointments made by September.
With the economic climate causing many practices to postpone recruitment or reduce support and training for new qualified graduates, competition for places on schemes such as this is expected to be high this year.
Brodie said: "The first twelve months out of vet school can be the most daunting of a vet's career. They're suddenly thrust into a public facing role with little experience of communicating with clients or making a diagnosis. Many have limited surgical experience and even fewer have business acumen. They really need structured support and training to build their confidence and enable them to perform effectively both from a clinical and a business perspective. Mentoring is a key support tool so our graduates are all placed with practices where this can be provided regularly.
Feedback from our scheme last year showed that what the graduates we recruited most valued was working within a team which encouraged them to be open and honest so that they could readily ask for advice and help when they needed it. We're all individuals and perform much better if we feel comfortable with the people we're working with. Our scheme enables us to build on our graduates' strengths and support them in areas which they find more challenging.
We provide clinical and surgical training but also focus on the development of communication and management skills to help graduates fulfil their role as part of a business team. The graduates we appoint will each spend their first year based within one of our smaller practices, working as part of a small and closely knit team. At the end of the first year, if all is going well, they will have the option to stay on and help grow that practice.
In addition to veterinary skills, we're looking for graduates with a good personality fit, a strong work ethic, a caring approach and ideally some level of business understanding."
For further information on the scheme, please contact Brodie at Brodie@petdoctors.co.uk
Animalcare Marketing Manager, James Beaumont said: “Practice life is busier than ever and we know that practice teams are working very hard. It’s important that they are well-fuelled, so we aim to nourish their bodies and minds with our new Daxocox ‘Bitesize Lunch and Learns’. We’re simply asking practices to tell us their lunchtime desire and we’ll make sure that it’s delivered direct to their door.
"Then, in less time than it takes for them to demolish their feast, we’ll explain how breakthrough pain could be haunting their canine OA patients and, more importantly, how our new weekly NSAID, Daxocox, can help."
Practices can register for a lunch and learn and submit their lunch order by registering at www.daxocox.co.uk/lunch_learn or contacting Animalcare on 01904 487687.
The pair were invited to carry out the laparoscopic surgery on four dogs suffering from pulmonic stenosis by the British Veterinary Centre.
Chris Linney said: “The British Veterinary Clinic had previously referred a case to Fabio at Willows and subsequently got in touch about a further four cases in need of surgery, inviting us to fly out to Abu Dhabi to operate on these cases for them.
“It was a pioneering moment for the British Veterinary Centre and a first for the region and the Middle East.
“It’s the very first time that interventional cardiology has been performed in the UAE so, with the fantastic facilities and dedicated staff at the BVC, we have made history in the region!
“It was also the first time that Fabio and I had worked together and now we hope that this will be the first of many such collaborations.”
Fabio added: “With our collective expertise and knowledge, we know we can improve the lives of so many dogs that are living with conditions like pulmonic stenosis.
“Two of the dogs required balloon valvuloplasty and two required pulmonary stents inserted.
“All four dogs had great initial post-operative results and would be expected to lead happier, healthier lives as a result of these procedures.'
The British Equine Veterinary Association (BEVA) welfare award 2008, sponsored by The Blue Cross, has been presented to the Retraining of Racehorses (RoR) organisation for their contributions to equine welfare in support of the re-training and re-homing of racehorses.
The award, which was introduced by BEVA in conjunction with The Blue Cross animal welfare charity eight years ago, is a formal recognition of significant contributions made by veterinary surgeons and others to equine welfare.
It was presented to Ron Huggins, trustee of the ROR and an owner and breeder of racehorses, at the 47th BEVA Annual Congress in Liverpool on Friday 12 September 2008, by Kerstin Alford, equine welfare director of The Blue Cross.
Kerstin said: "The financial support that RoR provides for charitable racehorse rehabilitation centres, together with their education programme to help owners and riders of former racehorses, make them very worthy recipients of this award."
Di Arbuthnot, director of operations said: "RoR are delighted to receive this prestigious award to recognise the work the charity does for former racehorses to provide them with a life after racing."
Retraining of Racehorses was established in 2000 by the British Horseracing Authority. Its aim is to raise funds from the British racing industry to provide and maintain facilities for the care, retraining and rehoming of former racehorses. Under the direction of the chairman of the trustees Peter Deal, the RoR has become recognised as a vital component of the racing industry.
The Blue Cross was founded in 1897 to care for working horses on the streets of London, and equine welfare still plays a vital role in its work today. The charity rehabilitates and rehomes over a hundred horses and ponies every year at its equine centres in Burford (Oxon) and Rolleston-on-Dove (Staffordshire). A third facility in Northiam (East Sussex) provides rest and retirement for Blue Cross equines.
Vets Now, the out-of-hours emergency services provider is to launch the Vets Now Hospital service in Glasgow city centre, where it will offer emergency and critical care together with a range of specialist referral options.
This follows on the heels of The University of Glasgow Small Animal Hospital, a new £15 million facility which opened at the end of August.
Vets Now says that the new hospitals and the range of clinical services on offer to the profession and pet owners will make the west of Scotland a centre of excellence in advanced clinical care for animals.
The opening of the two facilities will also offer both organisations a new platform on which to develop further their long standing relationship through future collaboration in the areas of teaching, training and investigation into animal disease.
Vets Now Group Managing Director, Richard Dixon said: "The opening of the two facilities presents a number of opportunities for both organisations to work collaboratively to develop teaching and training for undergraduates, residents, interns and nurses, and to work together to gain further understanding into animal disease through clinical investigation and the practice and promotion of evidence based medicine."
Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University said: "The expanded service which will be offered by the Small Animal Hospital and the new Vets Now Hospital obviously presents an enhanced range of choices for pet owners and first opinion vets in Scotland and an opportunity for both organisations to work collaboratively to ensure that undergraduates and clinical professionals have access to the best training and opportunities to develop professionally. We have enjoyed a mutually beneficial relationship for a number of years and we look forward to the new opportunities which the opening of the two hospitals will bring in the future."
The Small Animal Hospital opened on 31 August. The first Vets Now Hospital will open in Glasgow on 31 October.
The panel, chaired by veterinary ethicist Professor David Morton CBE, was established last year on a trial basis as a means of offering an ethical review process for practice-based research projects that may not have the same access to resources as clinical studies in academia or industry.
Since its establishment at the end of July last year it has received 23 applications, mostly concerning small animal clinical studies. However, due to demand from the profession, it will shortly be considering applications for equine or farm animal-based research and will be recruiting new panel members to cover these areas.
Eleanor Ferguson, RCVS Registrar, said: "Although the number of cases considered so far have been relatively small, the service has been very well received as a means of providing ethical review to those who might not otherwise be able to do so and so, therefore, might struggle to get papers published.
"Considering the importance of practice-based research we expect there to be an increase in the number of applications as word gets out about the service and so are happy to extend the trial for another year and for it to consider a wider range of applications."
Further details about the Panel, as well as guidelines for making applications and the application forms, can be found at www.rcvs.org.uk/ethics
For an initial discussion about submitting an application to the Ethics Review Panel, contact Beth Jinks, Standards and Advisory Officer, on 020 7202 0764 or ethics@rcvs.org.uk
FMDMost of you will be aware that IP8 was declared yesterday. This is a farm in the POZ that was slaughtered on suspicion after detection during surveillance visits. This has lead to further slight changes in the boundaries of the PZ and SZ. These were early lesions and initial laboratory results confirm this.
The epidemiology of the spread of FMD in the area north of Egham suggests that cattle on 4 premises in the vicinity of IP8 have been exposed to infection either via possible aerosol or fomite spread and are likely to develop disease. These premises will be culled as dangerous contacts.
BLUETONGUEThe various zones for controlling Bluetongue have now been defined. These are difficult to describe because they use roads etc. as boundaries but detailed maps and description of the boundaries are available at:
http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/pdf/declaration-bt-pzcz290907.pdf
When farms straddle a road that is a boundary the whole of the farm is classed as being in the zone. It may be possible to put parts of a holding that is outside the zone as a separate unit with consultation with local Animal Health office.
The movement restrictions between the various FMD and BT zones are available at
http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/movements/index.htm
Defra are worried that farmers are not reporting cases of BT because they feel there is nothing that can be done so why bother. It is still a notifiable disease and there is a need to monitor spread for various trade implications. There are, of course, likely to be welfare considerations with clinically affected cases. These will need to be addressed with veterinary consultation and may involve symptomatic treatment or euthanasia.
The prevalence of the disease in infected herds/flocks is still low with 1:53 and 1:190 being affected on surveillance.
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
To get involved, you can use the downloadable fundraising pack, which includes ideas, tips and tricks to help you fundraise.
In return for taking part, your practice will have its logo published on the BSAVA website, and BSAVA PetSavers will promote any fundraising posts on social media, using the hashtag #TeamPetSavers.
Shelby Tunstall, Fundraising Coordinator for BSAVA PetSavers said: “We are really delighted to be launching this campaign which will help PetSavers fund more research projects for companion animals."
If you want to get involved, you're encouraged to register online here, or contact Shelby Tunstall, Fundraising Coordinator at petsaversadmin@bsava.com.
https://www.bsava.com/petsavers/get-involved/petsaversinpractice.
Until now, research in equine veterinary science has focused primarily on the information needed to prevent and cure disease, with little attention paid to the attitudes and actions of horse owners, veterinary surgeons, and numerous other professionals to implementing science-based advice.
This special EVJ collection showcases studies that seek to understand horse owner behaviour around their horse’s health, supplementing clinical evidence with information about the real-life behaviours of equine owners and professionals and the factors that influence them.
It includes papers on horse owner knowledge and opinions on recognising colic, treating infectious disease, uptake of some of the most basic preventive health measures such as vaccination and deworming as well as attitudes and behaviour around equine obesity and laminitis.
Other studies highlight the importance of professionals other than vets such as farriers, equine podiatrists, physiotherapists, dental technicians, chiropractors, and equestrian organisations such as the British Horse Society.
Guest Editor Tamzin Furtado added: “As our understanding of the drivers of behaviour develops, pre-existing behaviour change models will help us to understand the barriers and enablers to uptake.
“With dissemination of this knowledge, we have a better chance of communicating effectively and implementing change that will have a positive impact on equine welfare at individual, community, and national level.”
Professor Celia Marr, Editor of the EVJ said: “This collection is both compelling and eye-opening.
"It is dangerous to assume an understanding of the motivators of horse owner behaviours and actions; these papers confirm the current lack of comprehension, providing an invaluable insight, which will ultimately help us to accelerate improvements in equine veterinary practice and, most importantly, equine welfare.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.owner-behaviours and will be free to view until 26 December 2022.
The webinars will be presented by Professor Ian Ramsey, Ellen Behrend, Joezy Griffin, Professor Jill Maddison and Imogen Schofield.
They'll focus on the diagnosis, management and treatment of dogs with Cushing’s and will include information about Dechra’s predictor tool to help vets identify and progress suspected Cushingoid cases to a definitive diagnosis.
The webinars will also cover the importance of ongoing monitoring to optimise control of the syndrome and practical tips and tricks to help owners maximise compliance and optimise the quality of life of patients.
The full webinar schedule is as follows:
Cyclofin contains two active ingredients: 200 mg/ml of the anti-inflammatory flunixin-meglumine (eq. to 33.2 mg/ml flunixin meglumine) and 300 mg/ml of the class D anti-infective, oxytetracycline (eq. to 323.5 mg/ml oxytetracycline trihydrate).
Dechra says Cylofin acts within 24-36 hours and has sustained anti-bacterial activity for five to six days following a single intramuscular injection.
Administration is deep intramuscular injection in cattle and Cyclofin has a 35-day withdrawal period and a memorable dose rate of 1 ml per 10 kg body weight.
Alana McGlade MRCVS, national sales manager at Dechra, said: “BRD is one of the most prevalent and costly diseases on farm and early administration of an effective and fast-acting NSAID/antibiotic combination treatment, such as Cyclofin, can help relieve discomfort and stress, alleviate pain and improve demeanour and food intake.”
Cyclofin is available in 100ml vials.
https://www.dechra.co.uk/products/livestock/prescription/cyclofin#Cyclofin-300mg-ml.
Purina is inviting practices to participate in its inaugural UK Feline Dental Health Month, which starts on 1st July 2014.
As part of the initiative, participating practices are being asked to give their cat-owning clients free dental health checks throughout July to help improve the health of feline patients, build client loyalty and boost revenue.
Purina says Feline Dental Health Month has been created to help practices educate cat-owning clients about the importance of dental health. As many cat owners are unable or unwilling to check their cat's mouth and teeth due to the discreet nature of their pet, they rely on their vet to highlight potential problems. Feline dental disease is estimated to affect around three quarters of cats over the age of three, making it the most prevalent health condition seen amongst pet cats. Often painful and with the capability to cause systemic problems, dental problems in cats can represent a serious welfare problem if left untreated.
To help practices promote Feline Dental Health Month to their clients, Purina has prepared a support pack which includes waiting room promotional materials and client care leaflets with money off coupons. Practices will also be given a step-by-step publicity plan so they can promote the month in their local media and via their existing communications channels.
Purina says that signing up to the Feline Dental Health Month will mean that practices benefit from more contact with a client group that is potentially less engaged with their pet's health and also attract new clients via the promotional activity. This will provide an increase in opportunities to discuss other common health concerns with their clients and offer the potential to boost sales of products and services.
Chris Nickson, Senior Brand Manager, Purina Vet Channel said: "Feline Dental Health Month promotes the idea that prevention is better than cure. To avoid more serious procedures that can put stress on the owner and cat, Purina advocates ongoing management of dental hygiene. Our veterinary support packs provide everything a practice will need to have a very successful Feline Health Month."
Purina has also developed Pro Plan Cat Dental Plus, a diet designed to maintain healthy teeth and gums in cats. As part of Feline Dental Health Month, Purina is offering owners £5 off their first bag.*
To sign up for Feline Dental Health Month, speak to your Purina representative or call the Pro Plan Vet helpline on 0800 032 6418.
Insulation manufacturer Saint-Gobain Isover has published the results of a survey of 2000 homeowners which found that 36% are annoyed by noise made by neighbours' pets.
The Noise Report was commissioned to discover how many homeowners suffered with noisy next-door neighbours, to which the answer proved to be one in four.
According to the survey, which was carried out by Onepoll, Newcastle has the greatest percentage of owners who are disturbed by noise several times per day: 29.76% (click to enlarge infographic right).
In addition to noisy neighbours, 27% of homeowners said they are also disturbed by passing street traffic, while almost a third suffer from the sound of car and burglar alarms, and 36% are annoyed by noise from neighbours' pets.
The findings also suggested that external noise was more than just an irritation for homeowners. Almost a third of respondents said they lose sleep at night due to noise, while 15% claimed it causes them stress and anxiety. More than a fifth reported that they are unable to relax in their own home.
However, despite the impact of external noise on their quality of life, 45% of homeowners say they have not done anything about it. Only 6% report addressing the issue by installing insulation solutions in their homes.
Helen Tunnicliffe, head of marketing at Isover, said: "It is clear that noise from neighbours, traffic and other sources is a big problem for many homeowners. Not only is it irritating, it can have a major impact on people's emotional wellbeing.
"However, in spite of the seriousness of the issue, far too few people are taking measures to address it. There are many simple, easy-to-install solutions that prevent external noise in the home, such as insulation systems, which not only make the house warmer, but offer high acoustic performance too."
Alternatively, I suppose, move to Aberystwyth.
Vygon Vet, a division of Vygon (UK) Ltd, has announced the launch of its website - www.vygonvet.co.uk.
Vygon has been supplying the veterinary market for 15 years. The new website means the company's products can now be bought direct online. The range includes: Vascular Access, IV Management, Needle-Free Devices, Respiratory, Digestive Tract, Regional Anaesthesia, Tissue Adhesive, Urinary & Rectal Tract and Theatre Products.
In addition to product information and technical data, the website offers guidance notes and tips about basic procedures.
Les Davies, Managing Director of Vygon (UK) Ltd said: "The launch of the new website demonstrates our commitment to the veterinary market and we hope that it not only enables veterinary professionals to order our products with ease, but that they also find the guidance notes and advice a valuable resource for their practice."
Vygon Vet products can also be ordered by telephone or through your veterinary wholesaler.
The company says it aims to provide an updated and practical approach to this area of practice, using a combination of review lectures, case-based discussions and practical sessions.
David Babington, Managing Director of Improve said: "We’re delighted that, once our delegates have successfully completed all the requirements of the PgC Small Animal Dermatology, awarded by Harper Adams University, they will be able to use this as evidence of their achievement in an application to the RCVS for Advanced Practitioner status."
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.